Lincoln National Corporation
LNC
$42.20
-0.21%
Lincoln National Corporation is a diversified U.S. life insurance and retirement solutions provider operating through four core segments: Annuities, Retirement Plan Services, Life Insurance, and Group Protection, offering fixed and indexed annuities, variable annuities, universal and term life products, employer-sponsored retirement plans, and group life, disability, and dental coverage. As a mid-cap carrier with roughly 9,400 employees and a market capitalization near $8.3 billion, Lincoln is a spread-based, capital-intensive insurer rather than a technology-style disruptor, competing against larger peers such as MetLife, Prudential, and Equitable on distribution scale, product breadth, and balance-sheet strength. The current investor narrative is dominated by the interest-rate regime shift — a September 2026 Zacks piece highlighting the Fed's first rate hike since 2023 frames Lincoln as a potential beneficiary of higher-for-longer rates given its long-duration bond portfolio — while the company simultaneously works through volatile quarterly earnings (a Q1 2026 net loss of $172 million following a strong Q4 2025 profit of $754 million) and a deep valuation discount to book value. Debate centers on whether the rate tailwind and improving spread income can offset persistent GAAP earnings volatility, weak cash generation, and a consensus 'hold' rating that reflects lingering skepticism about the durability of the recovery.…
LNC
Lincoln National Corporation
$42.20
Related headlines
Investment Opinion: Should I buy LNC Today?
We assign a Hold rating on LNC. The core thesis is that the stock is deeply undervalued at 0.75x book but lacks a near-term catalyst to unlock value due to volatile earnings and weak cash flow. The analyst consensus is also Hold with an average target of $47.92, implying 13.6% upside, which is not compelling enough to justify a Buy given the risks.
The supporting evidence includes: 1) Revenue growth of 12.51% YoY in Q1 2026, showing top-line momentum; 2) A dividend yield of 5.11%, double the sector average, providing income; 3) A forward PE of 4.86x, which is extremely low and suggests the market expects earnings to grow substantially; 4) Analyst estimates for EPS of $10.65 in the forward period, which if achieved would make the stock very cheap. However, these positives are offset by a 0.28% ROA, 10.79% ROE, and negative EBITDA in Q1 2026.
The biggest risks that could invalidate the thesis are: 1) Continued quarterly losses, which would pressure the dividend and potentially lead to a cut; 2) A deterioration in credit quality within the investment portfolio, especially if rates rise further; 3) Failure to achieve the optimistic forward EPS estimates. The rating would upgrade to Buy if LNC demonstrates two consecutive quarters of stable operating earnings and ROE improves above 12%. It would downgrade to Sell if Q2 2026 shows another loss or if the dividend is cut. Relative to its history and peers, LNC is undervalued, but the discount is justified by its weak fundamentals until proven otherwise.
Sign up to view all
LNC 12-Month Price Forecast
LNC presents a classic value trap dilemma: extremely cheap on book value but with unproven earnings stability. The rate hike tailwind could be a game-changer if it lifts spread income, but the company's history of volatile quarterly results makes it difficult to underwrite. The analyst community is cautiously constructive, with a hold rating and a target just above the 52-week high, suggesting limited near-term upside. We would upgrade to bullish if LNC reports two consecutive quarters of stable operating earnings and ROE trends above 12%. We would downgrade to bearish if Q2 2026 shows another loss or if the dividend is cut. Until then, the risk/reward is balanced, and the stock is likely to remain range-bound.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lincoln National Corporation's 12-month outlook, with a consensus price target around $47.92 and implied upside of +13.6% versus the current price.
Average Target
$47.92
0 analysts
Implied Upside
+13.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$35 - $60
Analyst target range
Coverage on Lincoln is moderate, with 12 analysts contributing to the consensus. The recommendation is 'hold' with a recommendation mean of 2.54 (where 3.0 is a hold and lower is more bullish), and the average target price of $47.92 implies roughly 13.6% upside from the current $42.20. The consensus leans neutral-to-cautiously-constructive: the average target sits just above the 52-week high of $47.67, suggesting analysts see limited near-term upside, while the 'hold' rating reflects the tension between the deep valuation discount and the volatile earnings record.
The target range is wide, from a low of $35.00 to a high of $60.00, a spread of 71% that signals significant disagreement about the company's trajectory. The $60 high target implies roughly 42% upside and would require meaningful multiple expansion — likely a re-rating toward book value or above, driven by sustained spread-income growth from higher rates and a normalization of GAAP earnings. The $35 low target implies about 17% downside and prices in continued margin compression, weak cash flow, or credit deterioration in the investment portfolio. Institutional ratings show a modestly constructive tilt: Barclays upgraded to Overweight from Equal Weight in July 2026, and firms including Jefferies (Buy), Wells Fargo (Overweight), Mizuho (Outperform), and KBW (Outperform) maintain positive ratings, while UBS and Evercore ISI remain Neutral/In Line. The pattern of upgrades and stable outperform ratings, combined with the wide target spread, suggests analysts see value but lack conviction on timing — a classic 'cheap but unproven' setup where the stock could re-rate sharply if the next few quarters show consistent profitability.
Bulls vs Bears: LNC Investment Factors
The bear case currently has stronger evidence due to LNC's persistent earnings volatility, weak cash flow, and relative underperformance. However, the bull case rests on a powerful valuation discount (0.75x P/B) and a potential rate-driven earnings recovery that could catalyze a re-rating. The single most important tension is whether the Q1 2026 loss was a seasonal anomaly or a sign of structural issues; if upcoming quarters show consistent profitability, the stock could surge toward book value, but continued losses would validate the bear thesis. The risk/reward is skewed positively only if the rate tailwind translates into durable spread income and GAAP earnings stabilize.
Bullish
- Deep discount to book value: LNC trades at just 0.75x price-to-book, far below the 1.0x+ typical for life insurers and its own 1.31x reading in Q3 2023. This discount prices in significant pessimism and offers substantial re-rating potential if earnings normalize.
- Rate hike tailwind for spreads: The Fed's first rate hike since 2023 (September 2026) benefits Lincoln's long-duration bond portfolio, as higher reinvestment yields should lift spread income. Zacks highlighted LNC as one of three insurers to buy on this theme.
- Revenue growth accelerating: Q1 2026 revenue rose 12.51% YoY to $5.306 billion, continuing a multi-quarter climb from $4.065 billion in Q2 2025. Growth is broad-based across Life, Annuities, and Group Protection segments.
- Analyst target implies upside: The average analyst target of $47.92 represents 13.6% upside from the current $42.20, with a high target of $60 (42% upside). Barclays upgraded to Overweight in July 2026, and several firms maintain Buy/Outperform ratings.
Bearish
- Highly volatile and erratic earnings: Q1 2026 swung to a net loss of $172 million (EPS -$0.90) after a $754 million profit in Q4 2025. This follows a -$722 million loss in Q1 2025, highlighting extreme quarterly earnings volatility that undermines investor confidence.
- Weak cash flow and liquidity: Trailing free cash flow is only $243 million, a mere 2.9% FCF yield, and the current ratio of 0.466 signals tight short-term liquidity. Q1 2026 operating cash flow of $138 million barely covered $120 million in dividends.
- Low profitability metrics: ROE of 10.79% and ROA of just 0.28% are modest for the sector, and the trailing net margin is only 6.46%. These weak returns justify the discounted valuation and raise questions about capital efficiency.
- Relative underperformance vs. market: LNC is up only 6.03% over the past year versus SPY's 15.01% gain, a -8.98% relative lag. Year-to-date, LNC is down 6.24% while SPY is up 11.70%, a -17.94% gap, indicating the market is not rewarding the recovery.
LNC Technical Analysis
Lincoln's shares are in a broad recovery uptrend that has stalled in recent weeks. The stock is up 6.03% over the past year and 24.82% over six months, but sits at $42.20, which is only about 88.5% of its 52-week high of $47.67 and roughly 31.1% above its 52-week low of $32.18 — positioning it in the upper-middle of its annual range rather than at an extreme. That mid-to-upper range location suggests the stock has recovered meaningfully from its lows but lacks the momentum signature of a stock pressing new highs, leaving room for either a breakout continuation or a range-bound fade. Notably, the 1-year gain of 6.03% badly lags SPY's 15.01% advance, producing a relative strength of -8.98% over 12 months, evidence that this is a laggard recovery rather than a leadership move.
Short-term momentum has clearly decelerated and is now diverging from the longer-term trend. The stock is down 2.94% over the past month versus a 13.53% gain over three months and 24.82% over six months, meaning the powerful spring-to-summer advance (from roughly $34 in March to a peak near $47 in early August) has given way to a pullback. The 1-month relative strength versus SPY is -1.98%, and year-to-date the stock is down 6.24% against SPY's +11.70%, a -17.94% relative performance gap — a stark divergence that signals the market is not rewarding Lincoln's recovery with the same enthusiasm as the broader index. The recent fade from the $47.67 high to $42.20 (a decline of about 11.5% from the peak) looks like a normal mean-reversion pullback within a recovery, but the negative YTD and 1-month readings argue against chasing strength until momentum stabilizes.
Key technical levels are well defined. Support sits at the 52-week low of $32.18, with secondary support around the $40 psychological area where the stock consolidated in July; resistance is the 52-week high of $47.67, and a decisive breakout above that level would confirm a new leg higher and likely draw momentum buyers. Conversely, a breakdown below $40 would threaten the recovery structure and put the $32.18 low back in play. With a beta of 1.114, Lincoln is about 11% more volatile than the market, and its max drawdown of -29.85% over the period underscores that this is a high-risk, rate-sensitive name where position sizing should account for meaningful downside swings.
Beta
1.11
1.11x market volatility
Max Drawdown
-29.9%
Largest decline past year
52-Week Range
$32-$48
Price range past year
Annual Return
+6.0%
Cumulative gain past year
| Period | LNC Return | S&P 500 |
|---|---|---|
| 1m | -2.9% | -0.5% |
| 3m | +13.5% | +2.3% |
| 6m | +24.8% | +16.6% |
| 1y | +6.0% | +14.8% |
| ytd | -6.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LNC Fundamental Analysis
Lincoln's revenue trajectory is growing but lumpy. Q1 2026 revenue came in at $5.306 billion, up 12.51% year-over-year from $4.716 billion in Q1 2025, continuing a multi-quarter expansion from $4.065 billion in Q2 2025 and $4.591 billion in Q3 2025 to $4.922 billion in Q4 2025. The segment mix shows Life at $1.785 billion, Annuities at $1.576 billion, Group Protection at $1.555 billion, and Retirement Plan Services at just $346 million, meaning growth is broad-based across the three large segments while Retirement Plan Services remains a small contributor. The steady top-line climb implies the investment case rests on scale and spread income rather than a single high-growth product line, which is typical for a mature life insurer but limits the upside surprise potential.
Profitability is highly volatile and currently under pressure. Q1 2026 produced a net loss of $172 million (EPS of -$0.90) with negative EBITDA of -$165 million and an operating margin of -4.64%, a sharp reversal from Q4 2025's $754 million profit (EPS $3.90) and 18.59% operating margin. The trailing net margin is 6.46% and gross margin is 57.34%, but the quarterly swings — from -15.31% net margin in Q1 2025 to +33.18% in Q4 2024 — reflect the mark-to-market and actuarial noise inherent to insurance earnings. The Q1 2026 loss narrowed dramatically versus the -$722 million loss in Q1 2025, which is an encouraging year-over-year improvement, but the company remains far from the consistent profitability investors would want to see before paying up for the stock.
Balance sheet and cash flow metrics are the weakest part of the story. Debt-to-equity is a manageable 0.59, but the current ratio of 0.466 signals tight short-term liquidity, and the trailing free cash flow of just $243 million against an $8.3 billion market cap implies a paltry FCF yield of roughly 2.9%. ROE of 10.79% and ROA of just 0.28% are modest for the sector, and the Q1 2026 cash flow statement shows operating cash flow of only $138 million against $120 million of dividends paid, meaning the dividend is barely covered by internally generated cash. The company is funding itself partly through financing activities ($1.159 billion net cash from financing in Q1 2026) and investment portfolio churn, which raises the risk profile if rates or credit conditions turn unfavorable.
Quarterly Revenue
$5.3B
2026-03
Revenue YoY Growth
+12.5%
YoY Comparison
Gross Margin
62.1%
Latest Quarter
Free Cash Flow
$243000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LNC Overvalued?
Because Lincoln generated positive trailing net income (EPS of $0.145 and trailing PE of 7.48x), the PE ratio is the appropriate primary metric, though the extremely low forward PE of 4.86x deserves scrutiny. The gap between the 7.48x trailing and 4.86x forward multiple implies the market expects earnings to grow substantially — consistent with analyst estimated EPS of $10.65 for the forward period — but this forward estimate looks disconnected from the trailing $0.145 EPS and the Q1 2026 loss, suggesting the forward figure may reflect operating earnings rather than GAAP results. The 0.75x price-to-book ratio is the more telling signal: the stock trades below book value, which for an insurer typically prices in concerns about asset quality, reserve adequacy, or return-on-equity below cost of capital.
Relative to the broader Financial Services sector, Lincoln screens as deeply discounted. A trailing PE of 7.48x and forward PE of 4.86x are well below typical life-insurance sector multiples in the low-to-mid teens, while the 0.75x P/B and 0.45x P/S are far below the sector's usual 1.0x-plus book multiples. The 5.11% dividend yield is roughly double the sector average, which partly explains the low valuation — the market is demanding a high yield to compensate for earnings volatility and weak cash flow coverage. The discount appears partially justified by Lincoln's 10.79% ROE, 0.28% ROA, and erratic quarterly results, but if the rate-hike tailwind lifts spread income and stabilizes earnings, the gap to peers could narrow.
Historically, Lincoln's valuation is near the low end of its own range. The P/B ratio of 0.75x compares to 0.66x in Q1 2026, 0.78x in Q4 2025, and 1.31x as recently as Q3 2023, while the P/S of 0.45x is far below the 1.28x recorded in Q1 2026 and the 1.73x in Q4 2025. The trailing PE of 7.48x is elevated only because trailing earnings are depressed; on a normalized basis the stock has rarely been this cheap relative to book. This positioning suggests the market is pricing in either a value opportunity if earnings normalize, or continued fundamental deterioration if the Q1 loss proves structural rather than seasonal.
PE
7.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 1x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
3.2x
Enterprise Value Multiple
Investment Risk Disclosure
Lincoln's financial and operational risks are significant. The company's earnings are highly volatile, with a Q1 2026 net loss of $172 million following a $754 million profit in Q4 2025, reflecting mark-to-market and actuarial noise. Free cash flow is weak at $243 million TTM, resulting in a paltry 2.9% FCF yield, and the current ratio of 0.466 indicates tight liquidity. The dividend, while yielding 5.11%, is barely covered by operating cash flow of $138 million in Q1 2026 against $120 million paid, raising sustainability concerns if earnings do not improve.
Market and competitive risks include valuation compression if earnings fail to normalize. LNC trades at 0.75x book and 7.48x trailing earnings, but these multiples could contract further if ROE remains below cost of capital. The stock's beta of 1.114 means it is 11% more volatile than the market, and its -29.85% max drawdown highlights significant downside risk. Competitive pressures from larger peers like MetLife and Prudential, along with regulatory headwinds in the insurance sector, could limit growth. Recent news of the Fed's rate hike is a double-edged sword: while it may boost spread income, it could also increase credit risks in the bond portfolio.
The worst-case scenario involves a continued deterioration in earnings, leading to a breach of the 52-week low of $32.18. If Q2 2026 results show another loss and the dividend is cut, the stock could plummet to the analyst low target of $35 or below, representing a 17% decline from the current $42.20. In a severe recession with credit defaults, the stock could retest its 52-week low of $32.18, a 23.7% drop. Investors could lose 17-24% from current levels in this adverse scenario.
FAQ
The key risks include: 1) Earnings volatility – Q1 2026 saw a $172 million loss, and future quarters could also disappoint; 2) Dividend sustainability – operating cash flow of $138 million in Q1 2026 barely covered $120 million in dividends, and a cut would likely trigger a sell-off; 3) Credit risk – a deterioration in the bond portfolio could lead to reserve charges; 4) Competitive pressures – larger peers like MetLife and Prudential may take market share. The most severe risk is a continued earnings slump leading to a breach of the 52-week low of $32.18.
Our 12-month forecast has three scenarios: bull case (25% probability) targeting $55-$60, driven by successful rate-driven earnings recovery; base case (55% probability) targeting $45-$50, assuming gradual improvement; and bear case (20% probability) targeting $32-$35, if losses continue or the dividend is cut. The base case is most likely, with the key assumption that LNC returns to profitability in Q2 2026 and maintains its dividend. The analyst average target of $47.92 aligns with our base case.
LNC appears undervalued on most metrics. It trades at 0.75x price-to-book, well below the 1.0x+ typical for life insurers and its own historical average of 1.31x in Q3 2023. The trailing PE is 7.48x and forward PE is 4.86x, both far below sector averages in the low-to-mid teens. However, the discount is partly justified by weak ROE (10.79%) and ROA (0.28%), as well as erratic earnings. The market is pricing in continued fundamental challenges, but if earnings normalize, the stock could re-rate significantly higher.
LNC is a good buy only for investors with a high risk tolerance and a long-term horizon. The stock trades at a deep discount to book value (0.75x) and offers a 5.11% dividend yield, but its earnings are highly volatile, with a Q1 2026 net loss of $172 million. Analyst consensus is hold with an average target of $47.92, implying 13.6% upside, which is modest. The biggest downside risk is a retest of the 52-week low of $32.18, representing a 24% decline. Therefore, it is suitable for value investors who believe in the rate-driven recovery story and can withstand short-term volatility.
LNC is more suitable for long-term investment (at least 2-3 years) due to its turnaround nature and high dividend yield. Short-term trading is risky given the stock's beta of 1.114 and earnings volatility. The company is in a mature industry with slow growth, so capital appreciation depends on multiple expansion and earnings normalization, which may take time. Investors should be prepared to hold through several quarters of lumpy results. A minimum holding period of 2 years is recommended to allow the rate tailwind and operational improvements to materialize.